A share price of DENTSPLY Sirona Inc [XRAY] is currently trading at $19.62, up 0.05%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The XRAY shares have gain 3.48% over the last week, with a monthly amount glided 3.81%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
DENTSPLY Sirona Inc [NASDAQ: XRAY] stock has seen the most recent analyst activity on January 23, 2025, when Jefferies downgraded its rating to a Hold and also revised its price target to $20 from $30. Previously, Evercore ISI downgraded its rating to In-line on January 07, 2025, and kept the price target unchanged to $20. On December 04, 2024, Mizuho initiated with a Neutral rating and assigned a price target of $21 on the stock. Leerink Partners downgraded its rating to a Market Perform. Needham reiterated its recommendation of a Buy and reduced its price target to $29 on October 25, 2024. Needham reiterated a Buy rating for this stock on August 20, 2024, but kept the price target unchanged to $34. In a note dated February 26, 2024, Leerink Partners initiated an Outperform rating and provided a target price of $42 on this stock.
DENTSPLY Sirona Inc experienced fluctuations in its stock price throughout the past year between $17.21 and $35.47. Currently, Wall Street analysts expect the stock to reach $20 within the next 12 months. DENTSPLY Sirona Inc [NASDAQ: XRAY] shares were valued at $19.62 at the most recent close of the market. An investor can expect a potential return of 1.94% based on the average XRAY price forecast.
Analyzing the XRAY fundamentals
Trailing Twelve Months sales for DENTSPLY Sirona Inc [NASDAQ:XRAY] were 3.90B which represents 0.42% growth. Gross Profit Margin for this corporation currently stands at 0.52% with Operating Profit Margin at -0.07%, Pretax Profit Margin comes in at -0.09%, and Net Profit Margin reading is -0.11%. To continue investigating profitability, this company’s Return on Assets is posted at -0.06, Equity is -0.14 and Total Capital is -0.05. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.93.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 19.43 points at the first support level, and at 19.23 for the second support level. However, for the 1st resistance point, the stock is sitting at 19.84, and for the 2nd resistance point, it is at 20.05.
Ratios To Look Out For
To put it in perspective, the Current Ratio for DENTSPLY Sirona Inc [NASDAQ:XRAY] is 1.25. Further, the Quick Ratio stands at 0.84, while the Cash Ratio is 0.19. Considering the valuation of this stock, the price to sales ratio is 1.00, the price to book ratio is 1.57.
Transactions by insiders
Recent insider trading involved Coleman Glenn, Former Officer, that happened on Jan 27 ’25 when 15759.0 shares were purchased. Director, LUCIER GREGORY T completed a deal on Nov 18 ’24 to buy 5000.0 shares. Meanwhile, Director LUCIER GREGORY T bought 1000.0 shares on Nov 15 ’24.
